Annovis Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-56.2	-25.33	-14.49	-5.46	-0.99	Upgrade
Share-Based Compensation	4.63	9.15	4.7	1.86	0.01	Upgrade
Other Operating Activities	11.61	-1.14	0.66	-0.37	0.51	Upgrade
Operating Cash Flow	-39.97	-17.31	-9.13	-3.97	-0.48	Upgrade
Share Issuance / Repurchase	17.34	0	46.74	12.04	0	Upgrade
Debt Issued / Paid	0	0	0	0	0.53	Upgrade
Other Financing Activities	-	-	-	-	-0.09	Upgrade
Financing Cash Flow	17.34	0	46.74	12.04	0.44	Upgrade
Net Cash Flow	-22.62	-17.31	37.61	8.07	-0.03	Upgrade
Free Cash Flow	-39.97	-17.31	-9.13	-3.97	-0.48	Upgrade
Free Cash Flow Per Share	-4.43	-2.12	-1.20	-0.63	-1.69	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).